title: General management strategy for epidermal growth factor receptor inhibitor-associated papulopustular eruption.
authors.affiliation: University of Vermont College of Medicine, Burlington, Vermont; University of California San Francisco, Department of Dermatology, San Francisco, California. Electronic address: benjamin.farahnik@med.uvm.edu.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Farahnik
authors.affiliation: Department of Dermatology, Stanford University School of Medicine, Stanford, California.
authors.forename: Bernice
authors.initials: B
authors.lastname: Kwong
authors.affiliation: University of California San Francisco, Department of Dermatology, San Francisco, California; Department of Dermatology, Palo Alto Foundation Medical Group, Mountain View, California.
authors.forename: Jenny
authors.initials: J
authors.lastname: Murase
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D004643:Emollients / Q000627:therapeutic use; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011537:Pruritus / Q000139:chemically induced; D017192:Skin Diseases, Bacterial / Q000209:etiology / Q000517:prevention & control; D013473:Sunscreening Agents / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000891:Anti-Infective Agents, Local; D000970:Antineoplastic Agents; D004643:Emollients; D009363:Neoplasm Proteins; D047428:Protein Kinase Inhibitors; D013473:Sunscreening Agents; D066246:ErbB Receptors
keywords: chemotherapy side effect; epidermal growth factor receptor inhibitor; management; papulopustular eruption; xerosis